跳至主要内容
临床试验/CTRI/2020/04/024818
CTRI/2020/04/024818招募中未知

A Randomized study to compare vaginal and sublingual routes of misoprostol following mifepristone for second trimester medical termination of pregnancy

PGIMER0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
PGIMER

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Females in above mentioned age group with singleton viable intrauterine pregnancy
  • 2.Gestational age 13-20weeks
  • 3.Women fulfilling the pre-requisites of Indian MTP Act, 1972

排除标准

  • 1.Prior 2 or more uterine surgeries
  • 2.Having either taken MTP pill from outside or self prescribed or with inevitable or incomplete abortion
  • 3.Moderate or severe anaemia(Hb <8gm/dl)
  • 4.Heart disease, uncontrolled HTN(140/90mmHg), bronchial asthma, coagulation disorder and any other medical illness
  • 5.Known hypersenstivity to mifepristone or misoprostol
  • 6.Hemodynamically unstable at the time of presentation
  • 7.Contra-indications to the use of mifepristone or misoprostol like ectopic pregnancy, inherited porphyria, chronic adrenal failure , on immunosuppressants
  • 8.Presence of vaginal discharge suggestive of vaginitis

研究者

发起方
PGIMER

相似试验